Note 13 - Equity Transactions (Tables)

12 Months Ended

Jun. 30, 2014

Stockholders' Equity Note [Abstract]

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]

	Fiscal Year Ended
	June 30,
	2014		2013
Anti-dilutive stock options		1,236,770		2,269,088
Anti-dilutive warrants		-		500,000
Anti-dilutive shares for convertible notes payable		8,230,769		8,230,769
Total anti-dilutive shares		9,467,539		10,999,857

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

				Weighted
				Average
				Exercise
	Options			Price
Outstanding as of July 1, 2012		2,915,338		$	5.54
Granted		-			-
Exercised		-			-
Terminated		(24,000	)		0.75
Expired		(92,500	)		1.47
Outstanding as of June 30, 2013		2,798,838			5.72
Granted		-			-
Exercised		(25,000	)		0.14
Terminated		(73,000	)		2.31
Expired		(976,318	)		9.04
Outstanding as of June 30, 2014		1,724,520		$	4.07
Exercisable at June 30, 2013		2,798,838		$	5.72
Exercisable at June 30, 2014		1,724,520		$	4.07

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]

									Weighted
									Average
							Weighted		Remaining				Weighted
Range of							Average		Contractual				Average
Exercise Price					Outstanding		Exercise Price		Life (years)		Exercisable		Exercise Price
$	0.14	-	$	0.15		487,750	$	0.14		4.5		487,750	$	0.14
$	3.05	-	$	3.05		182,100		3.05		3.4		182,100		3.05
$	3.13	-	$	3.13		50,000		3.13		1.4		50,000		3.13
$	3.86	-	$	4.10		72,000		3.97		1.4		72,000		3.97
$	5.29	-	$	6.93		931,170		6.38		0.6		931,170		6.38
$	7.48	-	$	7.48		1,500		7.48		2.5		1,500		7.48
$	0.14	-	$	7.48		1,724,520	$	4.07		2.5		1,724,520	$	4.07